ESLOY
Price
$152.42
Change
+$0.20 (+0.13%)
Updated
Sep 5 closing price
Capitalization
139.91B
40 days until earnings call
FLMNF
Price
$61.84
Change
-$2.16 (-3.38%)
Updated
Jul 29 closing price
Capitalization
5.33B
Interact to see
Advertisement

ESLOY vs FLMNF

Header iconESLOY vs FLMNF Comparison
Open Charts ESLOY vs FLMNFBanner chart's image
EssilorLuxottica
Price$152.42
Change+$0.20 (+0.13%)
Volume$30.31K
Capitalization139.91B
Fielmann Group AG
Price$61.84
Change-$2.16 (-3.38%)
Volume$108
Capitalization5.33B
ESLOY vs FLMNF Comparison Chart in %
Loading...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FLMNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLOY vs. FLMNF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLOY is a Hold and FLMNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ESLOY: $152.42 vs. FLMNF: $61.84)
Brand notoriety: ESLOY and FLMNF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ESLOY: 65% vs. FLMNF: 94%
Market capitalization -- ESLOY: $139.91B vs. FLMNF: $5.33B
ESLOY [@Pharmaceuticals: Other] is valued at $139.91B. FLMNF’s [@Pharmaceuticals: Other] market capitalization is $5.33B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLOY’s FA Score shows that 3 FA rating(s) are green whileFLMNF’s FA Score has 1 green FA rating(s).

  • ESLOY’s FA Score: 3 green, 2 red.
  • FLMNF’s FA Score: 1 green, 4 red.
According to our system of comparison, ESLOY is a better buy in the long-term than FLMNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLOY’s TA Score shows that 3 TA indicator(s) are bullish while FLMNF’s TA Score has 2 bullish TA indicator(s).

  • ESLOY’s TA Score: 3 bullish, 5 bearish.
  • FLMNF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, FLMNF is a better buy in the short-term than ESLOY.

Price Growth

ESLOY (@Pharmaceuticals: Other) experienced а -0.05% price change this week, while FLMNF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

ESLOY is expected to report earnings on Oct 16, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOY($140B) has a higher market cap than FLMNF($5.33B). ESLOY has higher P/E ratio than FLMNF: ESLOY (50.77) vs FLMNF (27.34). FLMNF YTD gains are higher at: 45.379 vs. ESLOY (30.529). ESLOY has higher annual earnings (EBITDA): 6.71B vs. FLMNF (399M). ESLOY has higher revenues than FLMNF: ESLOY (27.2B) vs FLMNF (2.33B).
ESLOYFLMNFESLOY / FLMNF
Capitalization140B5.33B2,628%
EBITDA6.71B399M1,680%
Gain YTD30.52945.37967%
P/E Ratio50.7727.34186%
Revenue27.2B2.33B1,168%
Total Cash3.16BN/A-
Total Debt14BN/A-
FUNDAMENTALS RATINGS
ESLOY vs FLMNF: Fundamental Ratings
ESLOY
FLMNF
OUTLOOK RATING
1..100
7246
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
1580
SMR RATING
1..100
9660
PRICE GROWTH RATING
1..100
4947
P/E GROWTH RATING
1..100
2839
SEASONALITY SCORE
1..100
5055

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FLMNF's Valuation (20) in the null industry is in the same range as ESLOY (33). This means that FLMNF’s stock grew similarly to ESLOY’s over the last 12 months.

ESLOY's Profit vs Risk Rating (15) in the null industry is somewhat better than the same rating for FLMNF (80). This means that ESLOY’s stock grew somewhat faster than FLMNF’s over the last 12 months.

FLMNF's SMR Rating (60) in the null industry is somewhat better than the same rating for ESLOY (96). This means that FLMNF’s stock grew somewhat faster than ESLOY’s over the last 12 months.

FLMNF's Price Growth Rating (47) in the null industry is in the same range as ESLOY (49). This means that FLMNF’s stock grew similarly to ESLOY’s over the last 12 months.

ESLOY's P/E Growth Rating (28) in the null industry is in the same range as FLMNF (39). This means that ESLOY’s stock grew similarly to FLMNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESLOYFLMNF
RSI
ODDS (%)
Bearish Trend 2 days ago
56%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
17%
MACD
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
17%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
16%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
18%
Advances
ODDS (%)
Bullish Trend 2 days ago
60%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
50%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
40%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
46%
Bearish Trend 2 days ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FLMNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CE48.732.30
+4.95%
Celanese Corp
SIDU1.190.01
+0.85%
Sidus Space
NMFC10.62-0.02
-0.19%
New Mountain Finance Corp
AON370.54-2.95
-0.79%
Aon plc
TLSI4.99-0.16
-3.11%
TriSalus Life Sciences

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
+0.13%
ESLOF - ESLOY
58%
Loosely correlated
-2.34%
SMMNY - ESLOY
41%
Loosely correlated
+0.80%
SAUHY - ESLOY
37%
Loosely correlated
+0.51%
CLPBY - ESLOY
33%
Poorly correlated
+2.59%
LZAGY - ESLOY
32%
Poorly correlated
+0.64%
More

FLMNF and

Correlation & Price change

A.I.dvisor tells us that FLMNF and CNMD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FLMNF and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLMNF
1D Price
Change %
FLMNF100%
N/A
CNMD - FLMNF
23%
Poorly correlated
+0.51%
ESLOY - FLMNF
2%
Poorly correlated
+0.13%
FZMD - FLMNF
2%
Poorly correlated
N/A
EKTAY - FLMNF
1%
Poorly correlated
+0.43%
FSPKF - FLMNF
1%
Poorly correlated
N/A
More